Equities

Eyenovia Inc

EYEN:NAQ

Eyenovia Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.5005
  • Today's Change0.000 / 0.10%
  • Shares traded942.39k
  • 1 Year change-70.38%
  • Beta1.7489
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Eyenovia Inc fell by 8.01m. Cash Flow from Financing totalled 19.79m or 522,232.45% of revenues. In addition the company used 23.84m for operations while cash used for investing totalled 3.97m.
Cash flow per share-0.7677
Price/Cash flow per share--
Book value per share-0.0425
Tangible book value per share-0.1522
More ▼

Balance sheet in USDView more

Eyenovia Inc has a Debt to Total Capital ratio of 120.24%, a lower figure than the previous year's 125.23%.
Current ratio0.4596
Quick ratio0.267
Total debt/total equity--
Total debt/total capital1.20
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.